Oxidative stress via NOX1 contributes to vascular calcification in patients with CKD, and a NOX1 inhibitor reduces the change [70], suggesting that reductions in oxidative stress via NOX1 may prevent vascular calcification in patients with CKD. Here, NOX1 is linked to chronic kidney disease.